ONO PHARMA USA, INC. is pursuing the clinical development of new drug candidates and aiming to commercialize in the US. ONO PHARMA USA, INC. was established as a US subsidiary of Ono Pharmaceutical Co., Ltd. (ONO) in 1998. ONO was founded in Osaka, Japan in 1717. ONO is an R&D-oriented pharmaceutical company committed to discovering and developing “first-in-class” medicines such as nivolumab, an anti-PD-1 antibody. ONO is focusing on oncology, immunology, neurology, and specialty research.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
No